Lung Cancer Clinical Trials in Nashville

Showing 761-780 of 799 trials

Family Quality of Life Among Families With a Member Who is a Cancer Patient

NCT00544336

RATIONALE: Developing a questionnaire that can be used to assess the quality of life among people who have a family member with cancer may help the study of cancer in the future. PURPOSE: This clinical trial is studying quality of life among families with a member who is a cancer patient.

Breast CancerColorectal CancerHead and Neck Cancer+3 more

Vanderbilt-Ingram Cancer Center366 participantsStarted Aug 2007

Nashville, Tennessee, United States • Nashville, Tennessee, United States • Nashville, Tennessee, United States

COMPLETEDPhase 2< 1 mile

Erlotinib vs. Standard Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) and Eastern Cooperative Oncology Group (ECOG)Performance Status (PS) 2

NCT00085839

The purpose of this noncomparative study is to obtain preliminary estimates of the efficacy of erlotinib and standard chemotherapy in patients with advanced, previously untreated nonsmall cell lung cancer (NSCLC) and an Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 2. The study will also evaluate the safety of single-agent erlotinib in this patient population.

Non-Small Cell Lung Cancer

OSI Pharmaceuticals103 participantsStarted Feb 2004

Greenbrae, California, United States • San Diego, California, United States • Fort Lauderdale, Florida, United States +16 more locations

Family Quality of Life Among Families With a Member Who is a Cancer Patient

Erlotinib vs. Standard Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) and Eastern Cooperative Oncology Group (ECOG)Performance Status (PS) 2

Lung Cancer Trials in Other Cities

Safety Study of XL147 (SAR245408) in Combination With Erlotinib in Adults With Solid Tumors

Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer

Study of XL281 in Adults With Solid Tumors

TLK286 (Telcyta) in Combination With Cisplatin for Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)

Weekly Docetaxel Versus Weekly Docetaxel/Gemcitabine in the Treatment of Non-Small Cell Lung Cancer in Elderly Patients

A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer

A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC

Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer

S9806: Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Study of AT-101 in Combination With Topotecan in Relapsed/Refractory Small Cell Lung Cancer

Phase II Study Alimta and Gemzar + Avastin as First Line Chemotherapy for Elderly Patients With Stage IIIB/IV NSCLC

Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer

Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain Metastases

Safety Study Using Weekly Infusions of BB-10901 in Patients With Small Cell Lung Cancer

Oltipraz in the Prevention of Lung Cancer in People Who Smoke

A Study of Nimotuzumab in Combination With External Radiotherapy in Non-Small Cell Lung Cancer

Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.

Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer

Other Conditions in Nashville